Japan’s general trading houses are steadily becoming a force to be reckoned with in the pharmaceutical industry — and not…
HOME > ACADEMIA
ACADEMIA
- Careful Approach Needed in Legislating for Clinical Research: JAMS Pres.
May 8, 2014
- VART Lead Investigator “Wants to Seriously Take University Advice” on Retracting Diovan Papers
May 2, 2014
- Claims of Superior Cardiorenal Protective Effects of Diovan “Cannot Be Supported”: Outside Investigation of VART Study
April 30, 2014
- Chiba University to Advise Researchers to Retract Diovan Papers
April 28, 2014
- US Journal Corrects COI Disclosure to Clarify Involvement of Shionogi and Eli Lilly Japan in Paper on “Pain in Depression”
April 23, 2014
- JSBMR’s Guidelines Recommend Alendronate, Risedronate as First-Line Therapies for Steroid-Induced Osteoporosis Based on Available Data
April 22, 2014
- Public Hospitals Seeking to Avert Penalty Fee Cuts for Low Price Settlements
April 14, 2014
- JSH Publishes New Hypertension Guidelines
April 3, 2014
- Tolvaptan Reduces Body Weight, Improves Congestive Symptoms; Adverse Reactions Seen in Less than 20% of Patients: Interim Analysis of PMS Data
March 26, 2014
- Edoxaban Subgroup Analysis of East Asian Patients “Consistent” with Global Study Results: Researcher
March 25, 2014
- Revised Treatment Guidelines for HER2-Positive Gastric Cancer Will Recommend Combination Therapy with Trastuzumab
March 25, 2014
- Current Tax Rules for Medical Fees Unreasonable, Litigation an Option: Major Hospital Chain
March 25, 2014
- Experts Disagree over Full-Introduction of GCP at JCS Meeting
March 24, 2014
- NCNP Research Group Confirms Efficacy of Tocilizumab for Neuromyelitis Optica
March 19, 2014
- Japan Hematology Society to Open Probe into SIGN Trial
March 19, 2014
- Lead Author to Revise COI Statement in Article Used to Promote Antidepressant Cymbalta
March 19, 2014
- Trial Investigators Brush Aside Concerns over CASE-J in US Journal
March 18, 2014
- JSH Guidelines to Strongly Recommend Beta Blockers for Patients with Certain Complications
March 18, 2014
- University of Tokyo Admits Patient Information on SIGN Trial Leaked to Novartis
March 17, 2014
- National University Hospitals to Disclose Funding from Autumn, but with Company Names Withheld
March 11, 2014
ページ
A public-private council report outlining industry views on Japan’s drug pricing systems drew little discussion at a meeting of the…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
In the complex tapestry of leadership, awareness isn’t just a desirable trait; it’s the bedrock upon which success is built. It’s the lens through which leaders perceive, interpret, and navigate the ever-shifting landscape of their organizations and industries. Without it,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…